Discover 1,424 paid clinical trials in Clearwater, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,424
DSLT for Reducing Medication in Glaucoma
for
Primary Open Angle Glaucoma, Ocular Hypertension
Location: Largo FL
Sponsor: The Eye Institute of West Florida
Sex: All
Age: 0+
Code: NCT07390890
Recruiting
Lacrifill for Ocular Surface Optimization in Cataract Surgery
for
Cataract
Location: Largo FL
Sponsor: The Eye Institute of West Florida
Sex: All
Age: 40+
Code: NCT07648095
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Location: Largo FL, Clearwater FL, St. Petersburg FL, Trinity FL,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222566
Phase 3, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Largo FL, Oxford FL, Gainesville FL, Jacksonville FL,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase 2, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Largo FL, Sarasota FL, Lakeland FL, Jacksonville FL,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
for
Prostatic Neoplasms
Location: Largo FL, Lafayette LA, Germantown TN, Carmel IN,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT07832292
Phase 2, Recruiting
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
for
Non-Muscle Invasive Bladder Neoplasms
Location: Largo FL, Atlanta GA, Myrtle Beach SC, Lafayette LA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06919965
Phase 3, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),
Location: Largo FL, Myrtle Beach SC, Dalton GA, Ringgold GA,
Sponsor: Pfizer
Sex: Male
Age: 18+
Code: NCT07028853
Phase 3, Recruiting
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Largo FL, Riverview FL, Ocala FL, Daytona Beach FL,
Sponsor: Dendreon
Sex: Male
Age: 18+
Code: NCT06134232
Phase 2, Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
for
Venous Thromboembolism, Deep Venous Thrombosis,
Location: Tampa FL, Sarasota FL, Spartanburg SC, Nashville TN,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT05701917
Recruiting
The PREDICT Registry:
for
DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Location: Tampa FL, Jacksonville FL, Atlanta GA, Nashville TN,
Sponsor: PreludeDx
Sex: Female
Age: 30 - 70+
Code: NCT03448926
Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
for
Heart Failure, Heart Failure NYHA Class II,
Location: Clearwater FL, Tampa FL, Orlando FL, Jacksonville FL,
Sponsor: CVRx, Inc.
Sex: All
Age: 18+
Code: NCT07232030
Recruiting
NORM-HF Pivotal Study
for
Heart Failure, NYHA Class III Heart Failure,
Location: Tampa FL, Jacksonville FL, Columbia SC, Greenville SC,
Sponsor: Foundry Innovation & Research 1, Limited (FIRE1)
Sex: All
Age: 18+
Code: NCT07574593
Recruiting
A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
for
Crohn's Disease, Ulcerative Colitis
Location: Largo FL, Tampa FL, New Port Richey FL, Bradenton FL,
Sponsor: AbbVie
Sex: All
Age: 18 - 70+
Code: NCT07697456
Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
for
Myasthenia Gravis
Location: Clearwater FL, Maitland FL, Greenville SC, New Bern NC,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07673744
Phase 2, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)